Texas passed a landmark law in June 2025, supported by former Gov. Rick Perry, that allocates US$50 million to support research on ibogaine, one of the most powerful psychedelics, for treating opioid ...

— Study Published in Psychopharmacology and Presented at the 12 th Clinical Trials on Alzheimer’s Disease (CTAD) Shows Favorable Safety and Tolerability Profile of Regular Low Dose LSD —Scientific ...

Researchers are investigating whether the drug could be used in mainstream medicine—with and without its hallucinatory effects.

Vision – To be the world's leading and most trusted provider of information and services that will make a real difference in clinical practice and improve outcomes for patients. Mission – To lead the ...

Drugs targeting receptors of the neurotransmitter serotonin (5-hydroxytryptamine [5-HT]) are widely used in neuropsychiatry and some such agents, most notably psilocybin, have shown potential for ...

NO drug used by man has stimulated greater public-debate than lysergic acid diethylamide (LSD). This brief review of the current status of the drug will summarize its pharmacology, medical uses and ...